How PepGen’s Jane Larkindale and Alayna Tress Advocate for Patient-Centricity in Rare Disease Drug Development
source: pixabay.com

How PepGen’s Jane Larkindale and Alayna Tress Advocate for Patient-Centricity in Rare Disease Drug Development

Contributed by Jane Larkindale and Alayna Tress While millions of people globally are living with a rare disease, patients often find it difficult to feel seen or heard throughout their…

Continue Reading How PepGen’s Jane Larkindale and Alayna Tress Advocate for Patient-Centricity in Rare Disease Drug Development